[Eales' syndrome. Clinical aspects, therapeutic indications and course of 29 cases].
Biomicroscopic examination of these cases showed vitreous hemorrhages in 18 eyes, retinal hemorrhages in 18 eyes, periphlebitis in 16 eyes, equatorial neovascularization in 16 eyes, macular involvement in 9 eyes (macular-cystoïd edema or macular pucker), prepapillary neovascularization in 15 eyes. Fluorescein retinal angiography was performed when it was possible. Follow up of these eyes upon and over six months, treated by corticotherapy for 11 eyes, retinal photocoagulation for 32 eyes, and vitrectomy for 9 eyes, led to separate non evolutive entities (30 eyes) from evolutive entities (6 eyes). Complications happened in 15 eyes, 4 eyes ended with neovascular glaucoma. 40 eyes maintained ambulatory or calibrated acuity.
D000293:Adolescent; D000328:Adult; D002196:Capillaries; D005128:Eye Diseases / Q000209:etiology; D005260:Female; D006801:Humans; D007511:Ischemia / Q000150:complications* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000175:diagnosis; D012008:Recurrence; D012166:Retinal Hemorrhage / Q000209:etiology* / Q000628:therapy; D012171:Retinal Vessels; D013577:Syndrome; D013997:Time Factors; D014822:Vitreous Body
Le syndrome d'Eales. Aspects cliniques, indications thérapeutiques et évolution de 29 observations.